Doxorubicin Hydrochloride Liposome Injection, Suspension, Liposomal
Product Images NDC 25021-263

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride Liposome (NDC 25021-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Dox0e 0000 01)

Structural Formula (Dox0e 0000 01)
FDA Label Image

Mpeg-dspe Structural Formula (Dox0e 0000 02)

Mpeg-dspe Structural Formula (Dox0e 0000 02)
FDA Label Image

Hspc Structural Formula (Dox0e 0000 03)

Hspc Structural Formula (Dox0e 0000 03)
FDA Label Image

Representation Of A Pegylated Liposome (Dox0e 0000 04)

Representation Of A Pegylated Liposome (Dox0e 0000 04)
FDA Label Image

Figure 1 (Dox0e 0000 05)

Figure 1 (Dox0e 0000 05)
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dox0e 0000 06)

Package Label – Principal Display Panel – Vial Label (Dox0e 0000 06)
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dox0e 0000 07)

Package Label – Principal Display Panel – Vial Label (Dox0e 0000 07)
This is a liposomal formulation of DOXORUBICIN Hydrochloride with a concentration of 2 mg per mL. Each vial contains 50 mg of the drug in 25 mL. It is indicated not to substitute for standard DOXORUBICIN Hydrochloride.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.